lobbying_filings_raw: 830b5b4e-ae0d-44f8-a7cb-bdf2f6fc8d95
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 830b5b4e-ae0d-44f8-a7cb-bdf2f6fc8d95 | Q3 | 284950 | MEHLMAN CONSULTING, INC. | 175611 | VIZIENT INC | 2021 | third_quarter | 2021-10-18T10:50:09.973000-04:00 | 60000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/830b5b4e-ae0d-44f8-a7cb-bdf2f6fc8d95/", "filing_uuid": "830b5b4e-ae0d-44f8-a7cb-bdf2f6fc8d95", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2021, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/830b5b4e-ae0d-44f8-a7cb-bdf2f6fc8d95/print/", "filing_document_content_type": "text/html", "income": "60000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Solveig L Monson", "dt_posted": "2021-10-18T10:50:09.973000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1341 G STREET, NW", "registrant_address_2": "Suite 1100", "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20005", "registrant": {"id": 284950, "url": "https://lda.senate.gov/api/v1/registrants/284950/", "house_registrant_id": 36893, "name": "MEHLMAN CONSULTING, INC.", "description": "Government Affairs Consulting Services", "address_1": "1341 G Street, NW", "address_2": "Suite 1100", "address_3": null, "address_4": null, "city": "WASHINGTON", "state": "DC", "state_display": "District of Columbia", "zip": "20005", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "SOLVEIG MONSON", "contact_telephone": "+1 202-585-0292", "dt_updated": "2026-01-28T10:41:32.285626-05:00"}, "client": {"id": 175611, "url": "https://lda.senate.gov/api/v1/clients/175611/", "client_id": 1005977, "name": "VIZIENT INC", "general_description": "Healthcare services company", "client_government_entity": false, "client_self_select": null, "state": "TX", "state_display": "Texas", "country": "US", "country_display": "United States of America", "ppb_state": "TX", "ppb_state_display": "Texas", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2015-02-01"}, "lobbying_activities": [{"general_issue_code": "PHA", "general_issue_code_display": "Pharmacy", "description": "Issues related to Unapproved Drug Initiative.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 5659, "prefix": null, "prefix_display": null, "first_name": "DEAN", "nickname": null, "middle_name": null, "last_name": "ROSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 62201, "prefix": null, "prefix_display": null, "first_name": "LAUREN", "nickname": null, "middle_name": null, "last_name": "ARONSON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}, {"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Healthcare coverage; prescription drug costs; group purchasing issues; drug shortage issues.\n340B Drug Pricing Program. \nCOVID-19 supply chain and pharmaceutical, PPE, and other health care supply chain issues.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 5659, "prefix": null, "prefix_display": null, "first_name": "DEAN", "nickname": null, "middle_name": null, "last_name": "ROSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 62201, "prefix": null, "prefix_display": null, "first_name": "LAUREN", "nickname": null, "middle_name": null, "last_name": "ARONSON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "Healthcare transparency, costs and access to affordable medication and other healthcare items and services.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 5659, "prefix": null, "prefix_display": null, "first_name": "DEAN", "nickname": null, "middle_name": null, "last_name": "ROSEN", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 62201, "prefix": null, "prefix_display": null, "first_name": "LAUREN", "nickname": null, "middle_name": null, "last_name": "ARONSON", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |